Clinical Trials Logo

Benign Prostatic Hyperplasia clinical trials

View clinical trials related to Benign Prostatic Hyperplasia.

Filter by:

NCT ID: NCT06424912 Not yet recruiting - Clinical trials for Benign Prostatic Hyperplasia

Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis

Start date: August 30, 2024
Phase: N/A
Study type: Interventional

The study objective is to evaluate the safety and feasibility of the Vivifi's Treatment. The Vivifi's Treatment presents an innovative approach for addressing benign prostatic hyperplasia (BPH) as well as clinical/subclinical varicoceles in men. The scientific rationale for conducting this study is to assess the safety and feasibility of the Vivifi's Treatment (a surgical procedure) as a therapeutic intervention for patients with BPH.

NCT ID: NCT06380062 Completed - Clinical trials for Benign Prostatic Hyperplasia

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

Start date: January 12, 2012
Phase:
Study type: Observational

The aim of this study was to investigate plasma concentrations of one-carbon metabolites and phospholipid classes in participants with primary prostate cancer and those with benign hyperplasia. Moreover, the metabolites were studied in relation to tumor grade and age.

NCT ID: NCT06312722 Recruiting - Clinical trials for Benign Prostatic Hyperplasia

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

PEAK
Start date: February 7, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

NCT ID: NCT06282731 Completed - Clinical trials for Benign Prostatic Hyperplasia

The Changes of Urine Growth Factors Level

Start date: May 31, 2013
Phase: Early Phase 1
Study type: Interventional

The Changes of Urine Growth Factors Level in Patients With Benigh Prostate Hyperplasia after medical treatment.

NCT ID: NCT06275256 Not yet recruiting - Clinical trials for Benign Prostatic Hyperplasia

Outcomes of MIST for BPH: A Single-Institution Prospective Study

Start date: March 2024
Phase: Phase 3
Study type: Interventional

The investigators wish to perform a prospective study at the Men's Health Clinic in Winnipeg, Manitoba to accomplish two goals: 1) Prospectively describe 1 year outcomes for MIST therapies performed at the clinic 2) perform a head to head comparison of Rezum water vapor therapy vs the iTind device in respect to symptom score improvement, uroflow parameters and side effect profile.

NCT ID: NCT06266000 Recruiting - Clinical trials for Benign Prostatic Hyperplasia

Comparison of 2 Extracts of Saw Palmetto Versus Placebo on BPH Symptoms

Start date: March 1, 2024
Phase: Phase 4
Study type: Interventional

A randomized, double-blind, placebo-controlled, parallel group study to compare 2 extracts of saw palmetto versus placebo on the symptoms of benign prostate hyperplasia (BPH) in 120 generally healthy participants, 45 - 80 years.

NCT ID: NCT06263049 Completed - Clinical trials for Benign Prostatic Hyperplasia

Is Ejaculation Preservation TURis the Natural Evolution of the "Gold Standard".

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

evaluation of the impact of apical urethral mucosa sparring with the urethra around the verumontanum on the ejaculatory function and early postoperative urinary incontinence

NCT ID: NCT06260917 Completed - Clinical trials for Benign Prostatic Hyperplasia

The Effect of Urinating Through the Zipper or by Pulling Down the Trousers on Uroflowmetry Parameters in LUTS

Start date: November 1, 2023
Phase:
Study type: Observational

There are many factors that affect uroflowmetry parameters. One of these is the urination position. Research has mostly focused on standing and sitting urination positions. However, those who prefer the standing position as a habit can urinate by opening the zipper or lowering the trousers. Although the effect of these two applications on uroflowmetry parameters in healthy men has been investigated in only one study, their effect on patients with lower urinary tract symptoms has not been examined.

NCT ID: NCT06225479 Recruiting - Clinical trials for Benign Prostatic Hyperplasia

PRescription Exercise for Older Men With Urinary Disease

PROUD
Start date: January 3, 2024
Phase: N/A
Study type: Interventional

This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (LUTS/BPH) assessing a 12-week remote exercise intervention versus health education control.

NCT ID: NCT06212453 Not yet recruiting - Clinical trials for Benign Prostatic Hyperplasia

Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction

BETTANY
Start date: April 2024
Phase: Phase 2
Study type: Interventional

The aim of the current study is to evaluate the efficacy of transperineal focal microwave ablation (TMA) of the prostate transition zone as a new treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) within a prospective single-institutional pilot study.